Dwarf mice and the ageing process
What this study shows
Mice with growth hormone deficiency lived substantially longer than normal littermates - founding observation linking reduced growth-signaling to mammalian longevity.
At a glance
| Evidence type | A Animal model Marked A because it is an animal intervention or observation study measuring an organismal outcome (model: Ames dwarf mice (growth-hormone deficient)); the code names the system studied -- animal work can be rigorous and still not be human data. |
| Study type | 4 - Animal Study |
| Model system | Ames dwarf mice (growth-hormone deficient) |
| Journal | Nature |
| Year | 1996 |
| Peer reviewed | Yes |
| Record last updated | 2026-10-01 |
| Source | DOI 10.1038/384033a0 · PMID 8900272 |
Extracted findings
These fields were extracted from the paper with AI assistance and have not been checked against the source. Read them as a pointer into the paper, not as curated claims; where they disagree with the curated summary above, the curated summary stands.
| Intervention | Genetic – Ames dwarf mutation (GH/prolactin/TSH deficiency) |
| Target | GH/IGF-1 axis (upstream of PI3K-Akt-mTOR) |
| Model | Mouse (Ames dwarf) |
| Effect | Substantially longer lifespan vs normal littermates (both sexes) – early evidence linking reduced growth signaling to longevity |
In the Atlas
Related topics
More studies on this topic
- Disruption of the insulin/IGF-1 signaling pathway in Caenorhabditis elegans dramatically increases male longevity and enhances reproductive health late in life (2026)
- Midlife Growth Hormone Receptor Ablation Extends Healthy Lifespan and Induces Sex-Specific Hepatic Transcriptional Changes at Single-Cell Resolution (2026)
- Extending healthy life span--from yeast to humans (2010)
- Growth Hormone Receptor Antagonism Extends Lifespan (2026)
Was this page useful?
Thank you. Your answer was counted anonymously.